By Professor Marcel Dinger

Other

Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC, 2023, Data from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis, http://dx.doi.org/10.1158/1541-7786.c.6540525.v1

Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC, 2023, Data from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis, http://dx.doi.org/10.1158/1541-7786.c.6540525

Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC, 2023, Supplemental Files from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis, http://dx.doi.org/10.1158/1541-7786.22513437.v1

Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC, 2023, Supplemental Files from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis, http://dx.doi.org/10.1158/1541-7786.22513437

Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC, 2023, Supplementary Data from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis, http://dx.doi.org/10.1158/1541-7786.22513434

Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC, 2023, Supplementary Data from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis, http://dx.doi.org/10.1158/1541-7786.22513434.v1

Palmer EE; Hong S; Al Zahrani F; Hashem MO; Aleisa FA; Jalal Ahmed HM; Kandula T; Macintosh R; Minoche AE; Puttick C; Gayevskiy V; Drew AP; Cowley MJ; Dinger M; Rosenfeld JA; Xiao R; Cho MT; Yakubu SF; Henderson LB; Guillen Sacoto MJ; Begtrup A; Hamad M; Shinawi M; Andrews MV; Jones MC; Lindstrom K; Bristol RE; Kayani S; Snyder M; Villanueva MM; Schteinschnaider A; Faivre L; Thauvin C; Vitobello A; Roscioli T; Kirk EP; Bye A; Merzaban J; Jaremko Ł; Jaremko M; Sachdev RK; Alkuraya FS; Arold ST; Palmer E, 2019, Erratum: De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-progressive Neurocognitive Syndrome (The American Journal of Human Genetics (2019) 104(3) (542–552), (S0002929719300138), (10.1016/j.ajhg.2019.01.013)), Elsevier, http://dx.doi.org/10.1016/j.ajhg.2019.03.016

Back to profile page